Abstract
This report demonstrates variable clinical courses in several members of a family with tropomyosin-mediated hypertrophic cardiomyopathy (HCM) (L185R mutation). The index case was an 8-year-old girl who died from sudden cardiac death and was diagnosed with HCM on autopsy. Her father had minimal hypertrophy but had an implantable cardioverter defibrillator placed prophylactically with no appropriate shocks. Two brothers progressed from normal phenotype to HCM on follow-up, the younger with significant hypertrophy and the older with mild hypertrophy. They both had malignant arrhythmia courses with VF, which was terminated by ICD shock. In conclusion, family members with same genotype can have significantly variable phenotypes.
References
Maron BJ (2010) Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 121:445–456
Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308–1320
Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687–1713
Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ (1995) Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. Am Coll Cardiol 26:1529–1536
Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM (1999) Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 281:650–655
Van Driest SL, Will ML, Atkins DL, Ackerman MJ (2002) A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood. Am J Cardiol 90:1123–1127
Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TG et al (2000) Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population. Circulation 102:858–864
Australian national FHCM database. http://www.angis.org.au/Databases/Heart/heartbreak.html. Accessed 5 February 2010
Gould SE (1960) Pathology of the heart, 2nd edn. Charles C Thomas, Springfield, pp 1063–1065
Gurnett CA, Atkins DL (2000) Home use of a biphasic waveform automated external defibrillator in a high-risk 3-year-old child. Am J Cardiol 86:1051–1053
Poliac LC, Barron ME, Maron BJ (2006) Hypertrophic cardiomyopathy. Anesthesiology 104:183–192
McKenna WJ, Behr ER (2002) Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart 87:169–176
Christiaans I, Lekanne dit Deprez RH, Van Langen IM, Wilde AA (2009) Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy. Heart Rhythm 6:1366–1369
Decker JA, Rossano JW, O’Brian Smith E, Cannon B, Clunie SK, Gates C et al (2009) Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. Am Coll Cardiol 54:250–254
Menon SC, Ackerman MJ, Cetta F, O’Leary PW, Eidem BW (2008) Significance of left atrial volume in patients <20 years of age with hypertrophic cardiomyopathy. Am J Cardiol 102:1390–1393
Perkins MJ, Van Driest SL, Ellsworth EG, Will ML, Gersh BJ, Ommen SR et al (2005) Gene-specific modifying effects of pro-LVH polymorphisms involving the renin–angiotensin–aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur Heart J 26:2457–2462
Ackerman MJ, Van Driest SL, Ommen SR, Will ML, Nishimura RA, Tajik AJ et al (2002) Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: A comprehensive outpatient perspective. Am Coll Cardiol 39:2042–2048
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Makhoul, M., Ackerman, M.J., Atkins, D.L. et al. Clinical Spectrum in a Family with Tropomyosin-Mediated Hypertrophic Cardiomyopathy and Sudden Death in Childhood. Pediatr Cardiol 32, 215–220 (2011). https://doi.org/10.1007/s00246-010-9843-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-010-9843-1